OnLume

Executive Summary

OnLume is a private medical device company based in Madison, Wisconsin, developing advanced fluorescence imaging systems for real-time visual guidance during surgical oncology procedures. Founded in 2015, the company's technology aims to improve surgical precision by illuminating critical anatomical structures and cancerous tissues, potentially reducing recurrence rates and improving patient outcomes. The system is designed for intraoperative use, addressing a significant unmet need in oncology surgery where clear visualization of tumor margins is critical. OnLume operates in the growing market of image-guided surgery, which is driven by the increasing incidence of cancer and the demand for minimally invasive techniques. While the company is still in the pre-revenue stage and has not disclosed total funding or valuation, its technology has garnered interest from the surgical community. Key competitive advantages include proprietary fluorescence agents and imaging algorithms that offer high sensitivity and specificity. The company is likely preparing for regulatory submissions and clinical validations to support commercialization.

Upcoming Catalysts (preview)

• H1 2027FDA 510(k) Clearance for Fluorescence Imaging System65% success
• H2 2026Strategic Partnership with Surgical Robotics or Device Company50% success
• Q4 2026Publication of Clinical Trial Results in Peer-Reviewed Journal70% success